98 results
Page 2 of 5
8-K
EX-1.1
kw224ardt q3ll
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
8-K
EX-99.2
4ytsv g2u71jo4p
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
f2bnb
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
tb8jfozc p3
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.1
oiy6z1zn986k 37cn
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
ocrdr2f3jtg05y6o x7
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-10.3
25hr2 1v5
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
9h7 2jxl6q6ry
28 Aug 20
Prospectus supplement
4:31pm
425
k3pvhacvwhmz
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
6buyar
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-99.1
692sumkr 18z9vmxn
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.2
l578wcte1ow8
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm